Medical Communications

Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …

GW Pharma’s Epidiolex has become the first plant-derived, cannabis-based medicine to be made available on prescription in all 50 US …

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Thailand’s public health ministry is working to make medical marijuana legal by next month. The shift is expected to come …

England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …

India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …

It’s bad news for patients in the UK affected by chronic lymphocytic leukaemia (CLL) as the National Institute of Health …

The US Food and Drug Administration (FDA) has given psilocybin – the psychoactive ingredient in ‘magic mushrooms’ – breakthrough therapy …

An outbreak of measles threatens to decimate an isolated tribe in the Amazon, according to the non-profit organisation Survival International. …

Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …

MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …

Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …